Related Experiment Videos
Overview: immunotherapy for cancer--is it time for the kitchen sink?
1Medarex Inc, Bloomsbury, NJ 08804, USA. tdavis@medarex.com
Current Opinion in Investigational Drugs (London, England : 2000)
|June 11, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Neutrophil Gelatinase-Associated Lipocalin: A Shared Early Biomarker of Remote Organ Dysfunction in Blast-Induced Extremity Trauma.
International journal of molecular sciences·2025
Systemic inflammation following traumatic injury and its impact on neuroinflammatory gene expression in the rodent brain.
Journal of neuroinflammation·2024
Missing in action: A bibliometric analysis of military research in the medical literature since 1950.
The journal of trauma and acute care surgery·2024
Reporting disease control rates or clinical benefit rates in early clinical trials of anticancer agents: useful endpoint or hype?
Current opinion in investigational drugs (London, England : 2000)·2011
Abating progressive tissue injury and preserving function after CNS trauma: The role of inflammation modulatory therapies.
Current opinion in investigational drugs (London, England : 2000)·2010
Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosis.
Current opinion in investigational drugs (London, England : 2000)·2010
Tralokinumab, an anti-IL-13 mAb for the potential treatment of asthma and COPD.
Current opinion in investigational drugs (London, England : 2000)·2010
Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's disease.
Current opinion in investigational drugs (London, England : 2000)·2010
Pitrakinra, a dual IL-4/IL-13 antagonist for the potential treatment of asthma and eczema.
Current opinion in investigational drugs (London, England : 2000)·2010
Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.
Frontiers in oncology·2026
Brain barriers at the crossroads of glioma immune surveillance and immunotherapy response.
Nature reviews. Cancer·2026
Circulating levels of TL1A and its decoy receptor DcR3 in systemic sclerosis.
Clinical rheumatology·2026
Peripheral cytokine distinguish recent from Mycobacterium tuberculosis infection and active tuberculosis.
Frontiers in microbiology·2026